-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R272G0Q/va2Mjlm8vHCgwwEtUXUeCLq3bZ1221w1mDoNM9fWMQKqBNPnGeZ0H4h3 iqpUXJe2yLgLTwNptH6ivg== 0000014272-04-000021.txt : 20040130 0000014272-04-000021.hdr.sgml : 20040130 20040130161303 ACCESSION NUMBER: 0000014272-04-000021 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040130 FILED AS OF DATE: 20040130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOOPER ANTHONY C CENTRAL INDEX KEY: 0001277244 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 04556140 BUSINESS ADDRESS: STREET 1: BRISTOL MYERS SQUIBB CO STREET 2: RT 206 & PROVINCE LINE RD CITY: PRINCETON STATE: NJ ZIP: 08543 BUSINESS PHONE: 6098583952 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 3 1 hoo197.xml X0201 3 2004-01-30 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001277244 HOOPER ANTHONY C BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON NJ 08540 0 1 0 0 President US Pharmaceuticals Common Stock, $0.10 par value 52245 D Common Stock, $0.10 par value 1545.24 I By BMY Savings & Investment Program Common Stock, $0.10 par value 3675 I By Spouse Executive Option (right to buy) 62.95 2000-01-04 2009-01-03 Common Stock, $0.10 par value 30813.00 D Executive Option (right to buy) 59.78 2002-03-06 2011-03-05 Common Stock, $0.10 par value 36150.00 D Option (right to buy) 32.00 1998-03-04 2007-03-03 Common Stock, $0.10 par value 17878.00 D Option (right to buy) 48.45 1999-03-03 2008-03-02 Common Stock, $0.10 par value 25660.00 D Option (right to buy) 61.09 2001-01-03 2010-01-02 Common Stock, $0.10 par value 2524.00 D Option (right to buy) 42.64 2001-03-07 2010-03-06 Common Stock, $0.10 par value 33127.00 D Option (right to buy) 48.08 2003-03-05 2012-03-04 Common Stock, $0.10 par value 40000.00 D Option (right to buy) 28.90 2005-06-04 2007-06-03 Common Stock, $0.10 par value 30000.00 D Option (right to buy) 23.14 2004-03-04 2013-03-03 Common Stock, $0.10 par value 68000.00 D Includes shares of restricted stock with one-third vesting on each of the third, fourth and fifth anniversaries of the grant date. Based on a plan statement as of the end of the most recent fiscal quarter. One half of the shares is exercisable 25% per year, on a cumulative basis, commencing one year after the date of grant. The other half of the shares vests 25% per year and is exercisable on the earlier to occur of (i) the closing share price achieving a price threshold and remaining at that threshold for a given number of days or (ii) the eighth anniversary of the grant date. Currently Exercisable. Exercisable as to 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant. Exercisable on the earlier of (i) three years from the date of grant or (ii) the date on which the closing share price achieves $50.00 or above for seven consecutive trading days. By: /s/ Sandra Leung, Attorney-in-Fact 2004-01-30 EX-24 3 hooper.htm POWER OF ATTORNEY POWER OF ATTORNEY

POWER OF ATTORNEY

 

I, Anthony C. Hooper, President, U.S. Pharmaceuticals of Bristol-Myers Squibb Company, a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung and Sonia Vora, individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions.

IN WITNESS WHEREOF, I have executed this Power of Attorney on this 22nd day of January 2004.

 

 

_/s/ Anthony C. Hooper

Anthony C. Hooper

 -----END PRIVACY-ENHANCED MESSAGE-----